The Emory Integrated Genomics Core has acquired a new high-efficiency molecular profiling system, novel technology that will change the way researchers are able to translate genomic data into research discoveries.
Made possible by a generous gift from the SunTrust Trusteed Foundations - Nell Warren Elkin and William Simpson Elkin Foundation, the nCounter® SPRINT from NanoString Technologies provides a user-friendly way to conduct advanced analysis on a large number of samples. The nCounter® SPRINT can measure the gene expression, protein expression, and gene mutations of up to 800 targets in a single reaction. Because it uses molecular “barcodes” and single molecule imaging without any amplification, the nCounter® SPRINT is effective with challenging specimens such as older, degraded tumor biopsies. The resulting data holds promise for improved patient care through the development of new diagnostic, prognostic, and therapeutic tools including cancer immunotherapy and predictive biomarkers.
The Emory Integrated Genomics Core is supported by Winship Cancer Institute, Atlanta Clinical & Translational Science Institute, and Emory University School of Medicine. For more information about the nCounter® SPRINT system and other services, visit the Emory Integrated Genomics Core website.